INS and type 2 diabetes mellitus: A cohort study included 23 non-T2D depressed patients assigned to 11 patients on maprotiline and 12 patients on fluoxetine showed that maprotiline increased body weight and reduce insulin sensitivity as compared to fluoxetine [145, 146].